NORDIC PHARMACEUTICALS ApS: Financial statements 2020
CVR: 27430015
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
NORDIC PHARMACEUTICALS ApS (CVR 27430015) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 602,014 and a net result of DKK 57,931 compared with DKK 25,941 the year before. That is a decrease of 52.5% compared with the year before. Equity in the 2020 report amounted to DKK 1,347,369. The solvency ratio was 65.3%. The company had 3 employees in the financial year.
- Gross Profit
- DKK 602,014
- Profit/Loss
- DKK 57,931
- Equity
- DKK 1,347,369
- Total Assets
- DKK 2,062,115
- Employees
- 3
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | 602K | 58K | 1.3M | 3 |
| 2019 | - | 1.3M | 26K | 1.3M | 3 |
| 2018 | - | 1.1M | 34K | 1.3M | 3 |
| 2017 | - | 1M | 40K | 1.2M | 3 |
| 2016 | - | 1.4M | 145K | 1.2M | 3 |
Official annual report
How creditworthy is NORDIC PHARMACEUTICALS ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
NORDIC PHARMACEUTICALS ApS has published its annual report for 2019. Gross profit came to DKK 1,268,578, and the net result was DKK 25,941.
About NORDIC PHARMACEUTICALS ApS
NORDIC PHARMACEUTICALS ApS is a Danish company of the type Anpartsselskab based in Hvidovre, founded in 2003. The company is registered under the industry Fremstilling af andre fødevarer i.a.n.. The management consists of Lars Bo Holløse Nielsen. The board consists of Knud Benny Junge (chair). The company is owned by Lars Bo Holløse Nielsen and Kea Ok Junge. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK -165,886 and a net result of DKK -573,072 compared with DKK -2,664,416 the year before. Equity in the 2025 report amounted to DKK -1,725,613.